Antispasmodic

From Wikipedia, the free encyclopedia
Jump to: navigation, search

An antispasmodic (synonym: spasmolytic) is a drug or an herb that suppresses muscle spasms.[1][2]

Smooth muscle spasm[edit]

One type of antispasmodics is used for smooth muscle contraction, especially in tubular organs of the gastrointestinal tract. The effect is to prevent spasms of the stomach, intestine or urinary bladder. Both dicyclomine and hyoscyamine are antispasmodic due to their anticholinergic action. Both of these drugs have general side effects and can worsen gastroesophageal reflux disease.[3]

Mebeverine is a muscolotropic spasmolytic with a strong and selective action on the smooth muscle spasm of the gastrointestinal tract, particularly of the colon. It does not have the acetylecholine side effect commonly seen in an anticholinergic antispasmodic.

Papaverine is an opium alkaloid used to treat visceral spasms, erectile dysfunction and investigated as antipsychotic drug due to its potency to inhibit phosphodiesterase PDE10A.

Peppermint oil has been traditionally used as an antispasmodic, and a review of studies on the topic found that it "could be efficacious for symptom relief in IBS"[4] (as an antispasmodic) although more carefully controlled studies are needed. A later study showed it is an effective antispasmodic when test-applied topically to the intestine during endoscopy.[5]

Bamboo shoots have been used for gastrointestinal and antispasmodic symptoms. Anisotropine, Atropine, Cindinium Cap are also the most commonly used modern antispasmodics.

Skeletal muscle spasm[edit]

Pharmacotherapy may be used for acute musculoskeletal conditions when physical therapy is unavailable or has not been fully successful. Another class of antispasmodics for such treatment includes cyclobenzaprine, carisoprodol, orphenadrine, and tizanidine.[6] Effectiveness has not been clearly shown for metaxalone, methocarbamol, chlorzoxazone, baclofen, or dantrolene.[6] Applicable conditions include acute back or neck pain, or pain after an injury.

Spasm may also be seen in movement disorders featuring spasticity in neurologic conditions such as cerebral palsy, multiple sclerosis, and spinal cord disease. Medications are commonly used for spastic movement disorders, but research has not shown functional benefit for some drugs.[7][8] Some studies have shown that medications have been effective in decreasing spasticity, but that this has not been accompanied by functional benefits.[7] Medications such as baclofen, tizanidine, and dantrolene have been used.[6]

See also[edit]

References[edit]

  1. ^ Antispasmodic at eMedicine Dictionary
  2. ^ "Antispasmodic". Dorland's Medical Dictionary. 
  3. ^ "Treatment of Irritable Bowel Syndrome - December 15, 2005 -- American Family Physician". Retrieved 2007-08-14. 
  4. ^ Pittler MH, Ernst E (1998). "Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis". Am. J. Gastroenterol. 93 (7): 1131–1135. doi:10.1111/j.1572-0241.1998.00343.x. PMID 9672344. 
  5. ^ Hiki N, Kurosaka H, Tatsutomi Y et al. (2003). "Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial". Gastrointest. Endosc. 57 (4): 475–482. doi:10.1067/mge.2003.156. PMID 12665756. 
  6. ^ a b c Chou R, Peterson K, Helfand M (2004). "Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review". Journal of Pain Symptom Management 28 (2): 140–175. doi:10.1016/j.jpainsymman.2004.05.002. PMID 15276195. 
  7. ^ a b Taricco M, Adone R, Pagliacci C, Telaro E. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD001131 Taricco, M.; Adone, R.; Pagliacci, C.; Telaro, E. (2000). "Pharmacological interventions for spasticity following spinal cord injury". In Taricco, Mariangela. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001131.  edit.
  8. ^ Shakespeare D, Boggild M, Young CA. Anti-spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001332 Shakespeare, D.; Boggild, M.; Young, C. A. (2003). "Anti-spasticity agents for multiple sclerosis". In Shakespeare, David. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001332.  edit.

External links[edit]